Static Chart Context Therapeutics Inc. Nasdaq

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2024-07-16 EDT			5-day change	1st Jan Change
2.19 ^USD	-0.45%		+12.89%	+93.81%

05-08	Context Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
05-06	Context Therapeutics Inc. announced that it has received $99.992767 million in funding from Ally Bridge Group, Avidity Partners, LLC, Blue Owl Healthcare Opportunities, Deep Track Capital, LP, Driehaus Capital Management LLC, Great Point Partners, LLC	CI

Duration

Period